1 Department of Neonatal Intensive Care Unit, Affiliated Women and Children’s Hospital of Ningbo University, Ningbo, China 2 Department of Pediatric Surgery, Affiliated Women and Children’s Hospital ...

Copyright: Crown Copyright © 2025 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies ...

The Phase III API-CAT trial found that extended anticoagulant therapy with reduced-dose Eliquis (apixaban) was noninferior to the full-dose regimen in preventing recurrent venous thromboembolism in ...

Citation: Low-dose apixaban comparable to full dose for preventing venous thromboembolism recurrence in patients with cancer (2025, March 31) retrieved 24 April 2025 from https://medicalxpress.com ...

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...